On-Demand Webinar: Continuing the Conversation-The Future of Reimbursement for Cell and Gene Therapies
Expanding upon his presentation at the recent World EPA Congress, moderator Richard Macaulay and Precision Value & Health have assembled a unique panel of payers from UK, Germany, and Italy, plus experts within Precision to address how innovative reimbursement strategies for cell and gene therapies (C>s) will evolve.
Conference Video: Virtual ISPOR 2021
Congratulations to Richard Macaulay on his well-attended presentation “The New SMC-Ultra-Orphan Pathway: HTA Best Practice for Very Rare Diseases?” at Virtual ISPOR 2021. Did you miss Richard’s presentation?
Meeting on the Med 2021 Conference Panel: “Innovation: Shortening the Path to Commercialization in Advanced Therapies”
Clare Sarvary Fourrier, SVP of Operational Strategy (EU) for Precision for Medicine moderates this panel discussion with industry experts to share perspectives on the current state of the cell and gene therapy industry and provide key insights in shortening time-to-market for advanced therapies.
Upcoming Conference: Virtual ISPOR 2021
Attending Virtual ISPOR 2021 May 17-20? PRECISIONadvisors and PRECISIONheor will be attending with multiple posters, presentations, and workshops. Three posters and one presentation will have a special focus on Orphan diseases. Stay tuned for valuable insights from our experts that you won’t want to miss!
Conference Download: World EPA Congress
Did you miss PRECISIONadvisor’s Richard Macaulay present “The Future of Reimbursement for Cell & Gene Therapies” at World EPA Congress 2021? Don’t miss great insights about cell & gene therapy reimbursement challenges.